What is Fosrenol?
Fosrenol is the brand name for lanthanum carbonate, a medication used to treat hyperphosphatemia (high phosphate levels) in people with chronic kidney disease—including those on dialysis and those not yet on dialysis (often referred to as CKD stage 3–5, depending on the product label and indication). It works by binding phosphate in the gut so less is absorbed into the bloodstream.
How does Fosrenol compare with other phosphate binders?
Fosrenol is one option among several phosphate binders. In practice, the choice depends on what a patient is trying to avoid and tolerability, such as:
- Calcium-based binders (risk of calcium load)
- Sevelamer (non-calcium, non-metal polymer binders)
- Iron-based binders (in some markets and patients)
- Lanthanum carbonate (Fosrenol)
Clinicians generally pick based on individual lab patterns (phosphate and calcium), pill burden, gastrointestinal tolerance, and comorbidities.
What are common side effects patients ask about?
Because Fosrenol works in the gastrointestinal tract, side effects are often GI-related. Commonly reported issues for lanthanum carbonate products include constipation, nausea, dyspepsia/abdominal discomfort, and related GI complaints (the exact list and frequency come from the prescribing information for the specific formulation).
When do Fosrenol patents/exclusivity matter for generics?
If you’re looking at market timing for lower-cost competition, the key question is when patent protection and exclusivity end for lanthanum carbonate product formulations and related IP. Patent and exclusivity details can vary by country and by specific product/formulation, so it helps to check a dedicated patent-tracking source.
DrugPatentWatch.com tracks patent and exclusivity information for medicines, including Fosrenol-related filings. You can use it to see what is listed for the brand and where filings may be expiring: DrugPatentWatch.com: Fosrenol [1].
Is Fosrenol still on the market as a brand or generic?
Availability can differ by region. In some places, patients may see generic lanthanum carbonate or alternative phosphate binder products depending on how patent protection has played out and which manufacturers have entered the market. For the most accurate answer for your country, you’d need local formulary and approval status.
If I’m prescribed Fosrenol, how should it be taken?
Fosrenol is typically taken with meals so it can bind dietary phosphate in the gut. Many phosphate binders use a similar meal-based timing strategy. The precise dosing instructions should follow the specific product label for your formulation.
What happens if phosphate levels don’t come down on Fosrenol?
If phosphate targets aren’t met, clinicians usually review:
- Whether dosing timing with meals is correct
- Dietary phosphate intake
- Adherence and tolerability
- Whether a different binder (or combination therapy) is needed
- Overall CKD treatment plan, dialysis adequacy (if on dialysis), and related labs
---
Sources cited
[1] https://www.drugpatentwatch.com/p/fosrenol